Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Tax Rate (2013)

Updated

Vistagen Therapeutics (VTGN) recorded Tax Rate of 17709.92% in fiscal Q4 2013 (quarter ended Dec 31, 2013).

Analysis

Vistagen Therapeutics (VTGN) Tax Rate (2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 23.26%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn -
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 12.61%
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 8.85%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 17.54%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 20.70%
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 17,709.92%
API Access

Vistagen Therapeutics Tax Rate API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-rate&ticker=VTGN&period=max&api_key=YOUR_API_KEY